Vera Therapeutics Statistics
Total Valuation
VERA has a market cap or net worth of $1.40 billion. The enterprise value is $922.93 million.
Important Dates
The last earnings date was Tuesday, August 5, 2025, before market open.
Earnings Date | Aug 5, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
VERA has 63.82 million shares outstanding. The number of shares has increased by 24.94% in one year.
Current Share Class | 63.82M |
Shares Outstanding | 63.82M |
Shares Change (YoY) | +24.94% |
Shares Change (QoQ) | +0.18% |
Owned by Insiders (%) | 0.82% |
Owned by Institutions (%) | 91.16% |
Float | 46.94M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 2.99 |
P/TBV Ratio | 2.99 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 17.03, with a Debt / Equity ratio of 0.17.
Current Ratio | 17.03 |
Quick Ratio | 16.72 |
Debt / Equity | 0.17 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -31.58 |
Financial Efficiency
Return on equity (ROE) is -54.83% and return on invested capital (ROIC) is -31.85%.
Return on Equity (ROE) | -54.83% |
Return on Assets (ROA) | -30.24% |
Return on Invested Capital (ROIC) | -31.85% |
Return on Capital Employed (ROCE) | -43.31% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.95M |
Employee Count | 112 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, VERA has paid $1,000 in taxes.
Income Tax | 1,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -38.70% in the last 52 weeks. The beta is 1.17, so VERA's price volatility has been higher than the market average.
Beta (5Y) | 1.17 |
52-Week Price Change | -38.70% |
50-Day Moving Average | 22.71 |
200-Day Moving Average | 30.75 |
Relative Strength Index (RSI) | 53.27 |
Average Volume (20 Days) | 1,199,790 |
Short Selling Information
The latest short interest is 7.57 million, so 11.86% of the outstanding shares have been sold short.
Short Interest | 7.57M |
Short Previous Month | 8.24M |
Short % of Shares Out | 11.86% |
Short % of Float | 16.13% |
Short Ratio (days to cover) | 7.96 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -236.05M |
Pretax Income | -107.85M |
Net Income | -218.28M |
EBITDA | -235.77M |
EBIT | -236.05M |
Earnings Per Share (EPS) | -$3.59 |
Full Income Statement Balance Sheet
The company has $556.83 million in cash and $77.55 million in debt, giving a net cash position of $479.28 million or $7.51 per share.
Cash & Cash Equivalents | 556.83M |
Total Debt | 77.55M |
Net Cash | 479.28M |
Net Cash Per Share | $7.51 |
Equity (Book Value) | 468.28M |
Book Value Per Share | 7.34 |
Working Capital | 537.80M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$185.27 million and capital expenditures -$1.28 million, giving a free cash flow of -$186.55 million.
Operating Cash Flow | -185.27M |
Capital Expenditures | -1.28M |
Free Cash Flow | -186.55M |
FCF Per Share | -$2.92 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
VERA does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -24.94% |
Shareholder Yield | -24.94% |
Earnings Yield | -15.57% |
FCF Yield | -13.30% |
Dividend Details Analyst Forecast
The average price target for VERA is $64.29, which is 192.63% higher than the current price. The consensus rating is "Buy".
Price Target | $64.29 |
Price Target Difference | 192.63% |
Analyst Consensus | Buy |
Analyst Count | 8 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |